Clinical Trial Update: Effects of Endothelin Receptor Antagonist on Ischemic Kidney Injury During Nephron Sparing Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an endothelin receptor antagonist for reducing ischemic kidney injury during nephron-sparing surgery is ongoing with current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure

Snippet

Sponsor: Bnai Zion Medical Center | Conditions: Kidney Failure, Acute | Phase 2 | Status: UNKNOWN